Copper(II) PMDTA and copper(II) TMEDA complexes: precursors for the synthesis of dinuclear dicationic copper(II) complexes

Copper(II) cations coordinated with PMDTA (pentamethyldiethylenetriamine) and TMEDA (tetramethylethylenediamine) possess a high synthetic potential. The synthesis of these cations was carried out by metathesis reactions with silver salts. The cationic copper(II) complexes, [Cu(PMDTA)(Me₂CO)Cl]⁺, [Cu(PMDTA)(H₂O)Cl]⁺, [Cu(PMDTA)(DMF)]⁺, [Cu(PMDTA)Cl]⁺, [Cu(PMDTA)OAc]⁺, [Cu(PMDTA)(MeCN)₂]²⁺, [Cu₂(TMEDA)₂Cl₃]⁺ and [Cu(TMEDA)(MeCN)₃]²⁺ were synthesised as PF₆ salts, crystallised and characterised by single-crystal X-ray diffraction.     

Homoleptic copper(II) and copper(I) complexes of 5,6-dihydro-5,6-epoxy-1,10-phenanthroline. Six-coordinate copper(I) in solution

Reaction of 5,6-dihydro-5,6-epoxy-1,10-phenanthroline (L) with Cu(ClO₄)₂·6H₂O in methanol in 3:1 M ratio at room temperature yields light green [CuL₃](ClO₄)₂·H₂O (1). The X-ray crystal structure of the hemi acetonitrile solvate [CuL₃](ClO₄)₂·0.5CH₃CN has been determined which shows Jahn-Teller distortion in the CuN₆ core present in the cation [CuL₃]²⁺. Complex 1 gives an axial EPR spectrum in acetonitrile-toluene glass with g_|| = 2.262 (A_|| = 169 × 10⁻⁴ cm⁻¹) and g_⊥ = 2.069. The Cu(II/I) potential in 1 in CH₂Cl₂ at a glassy carbon electrode is 0.32 V versus NHE. This potential does not change with the addition of extra L in the medium implicating generation of a six-coordinate copper(I) species [CuL₃]⁺ in solution. B3LYP/LanL2DZ calculations show that the six Cu-N bond distances in [CuL₃]⁺ are 2.33, 2.25, 2.32, 2.25, 2.28 and 2.25 Å while the ideal Cu(I)-N bond length in a symmetric Cu(I)N₆ moiety is estimated as 2.25 Å. Reaction of L with Cu(CH₃CN)₄ClO₄ in dehydrated methanol at room temperature even in 4:1 M proportion yields [CuL₂]ClO₄ (2). Its ¹H NMR spectrum indicates that the metal in [CuL₂]⁺ is tetrahedral. The Cu(II/I) potential in 2 is found to be 0.68 V versus NHE in CH₂Cl₂ at a glassy carbon electrode. In presence of excess L, 2 yields the cyclic voltammogram of 1. From ¹H NMR titration, the free energy of binding of L to [CuL₂]⁺ to produce [CuL₃]⁺ in CD₂Cl₂ at 298 K is estimated as −11.7 (±0.2) kJ mol⁻¹.     

Solution-phase disproportionation equilibria for monosubstituted Pentakis- (arylisocyanide)cobalt(I) complexes by proton-NMR studies

Equilibrium constants, K_dis, for the solvent- dependent, solution-phase disproportionation equilibria of monosubstituted pentakis(arlisocyanide)cobalt(I) complexes: 2[Co(CNR)₄L]⁺?[Co(CNR)₃L₂]⁺ + [Co(CNR)₅]⁺, K_dis = $\text{[Co(CNR)}{}_3\text{L}{}_2\text{][Co(CNR)}{}_5\text{]}\text{[Co(CNR)}{}_4\text{L]}{}^2$ are measured by planimeter-integration of proton- NMR spectra at ambient temperature. The complexes, [Co(CNR)₄L]ClO₄, R = 2,6-Me₂C₆H₃, L = P(C₆H₅)₃, P(C₆H₄Cl-p)₃, P(OC₆H₅)₃, P(OC₆H₄Cl-p)₃; R = o-MeC₆H₄, L = P(C₆H₄Cl-p)₃, P(OC₆H₅)₃, P(OC₆H₄Cl-p)₃; R = 2,4,6-Me₃C₆H₂, L = P(C₆H₅)₃; R = 2,6-Et₂C₆H₃, L = P(C₆H₅)₃; are investigated in the deuterated solvents, CDCl₃, CD₃CN, (CD₃)₂CO, C₅D₅N, CD₃NO₂, and (CD₃)₂SO. Disproportionation seems to occur in all [Co(CNR)₄L]⁺, but NMR study is facilitated by utilizing equivalent alkyl protons (i.e., Me-groups) on the RNC ligands.Correlation of K_dis values with steric-hindrance of the RNC in sets of complexes with the same P-ligand is evident in all solvents: K_dis decreases with increased steric-hindrance in RNC. The K_dis values for complexes with the same RNC and analogous triarylphosphine, triarylphosphite ligands (i.e., PR₃, P(OR)₃, same R) are approximately equal. The K_dis values for complexes of P-ligands with Cl-substituent are significantly larger than K_dis values for complexes with the corresponding unsubstituted P-ligands (e.g., [Co(CNR)₄P(C₆H₄Clp)₃]ClO₄vs. [Co(CNR)₄P(C₆H₅)₃]ClO₄) in (CD₃)₂CO and C₅D₅N solution, but are smaller in CDCl₃ and CD₃CN, and approximately equal in CD₃NO₂ and (CD₃)₂SO. Properties of the solvents are also considered.     

Platinum(IV) isocyanide complexes

Neutral and cationic platinum(IV) isocyanide complexes of the type [PtCl₄(CNR)₂], [PtCl₄(CNR) (PMe₂Ph)], [PtCl₃(CNR)(PMe₂Ph)₂]⁺, [PtCl₂(CNR)₂ (PMe₂Ph)₂]²⁺, where R = methyl, t-butyl, cyclohexyl, p-tolyl, have been prepared by chlorine addition to the corresponding platinum(II) derivatives. The complexes [PtCl₂(CN)₂(CNR)₂] and [PtCl₂(CN)(CNR) (PMe₂Ph)₂]⁺ (R = t-butyl), are also reported. The cationic t-butylisocyanide derivatives are noteworthy in the way they readily lose the t-butyl cation at room temperature to give the corresponding cyano complexes. The compounds have been characterized by elemental analysis, molecular weights and conductivity measurements, and their i.r. and n.m.r. data are discussed in relation to structures and to the nature of the platinum-isocyanide bond.     

Synthesis and properties of crown ether isocyanide silver(I) derivatives: X-ray structure of a self-assembled 22-membered diargentacycle

The crown ether isocyanide CNR (R = benzo-15-crown-5) reacts with silver(I) salts in the appropriate molar ratio to give [Ag(CNR)_n]X (n = 1, 2; X = CF₃SO₃, BF₄). X-ray diffraction studies of [Ag(CF₃SO₃)(CNR)] show the molecules associated in a dinuclear manner with an antiparallel orientation. The silver centers are tetracoordinated to the isocyanide and to three oxygens, one from the triflate anion and two from the second crown ether in the dimer. The molecular structure displays five cycles: the two 15-crown ether rings, two five-membered argentacycles and a 22-membered diargentacycle. The crown ether in these complexes is able to detect alkaline cations from M(CF₃SO₃) (M = Li, Na, K) by NMR in d₆-acetone solutions, and to distinguish Li⁺-Na⁺ from K⁺.     

In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands

Hydrophilic, monocationic [M(L)₄]PF₆ complexes (M = Cu or Ag; L: thp = tris(hydroxymethyl)phosphine, L: PTA = 1,3,5-triaza-7-phosphaadamantane, L: thpp = tris(hydroxypropyl)phosphine) were synthesized by ligand exchange reaction starting from [Cu(CH₃CN)₄]PF₆ or AgPF₆ precursors at room temperature in the presence of an excess of the relevant phosphine. The related [Au(L)₄]PF₆ complexes (L = thp, PTA or thpp) were synthesized by metathesis reactions starting from [Au(L)₄]Cl at room temperature in the presence of equimolar quantity of TlPF₆. The three series of complexes [M(L)₄]PF₆ were tested as cytotoxic agents against a panel of several human tumour cell lines also including a defined cisplatin resistant cell line. These investigations have been carried out in comparison with the clinically used metallodrug cisplatin and preliminary structure-activity relationships are presented. The best results in terms of in vitro antitumour activity were achieved with metal-thp species and, among the coinage metal complexes, copper derivatives were found to be the most efficient drugs. Preliminary studies concerning the mechanism of action of these [M(L)₄]PF₆ species pointed to thioredoxin reductase as one of the putative cellular targets of gold and silver complexes and provided evidence that copper derivatives mediated their cytotoxic effect through proteasome inhibition.     

X-ray crystal structures of the copper(II), nickel(II) and silver(I) complexes of a 17-membered dibenzo macrocycle with a N3S2 donor set

The copper(II), nickel(II) and silver(I) complexes of the pentadentate 17-membered macrocycle 1, 12, 15-triaza-3, 4:9, 10-dibenzo-5,8-dithiacycloheptadecane (L¹) have been prepared as perchlorates and characterized by X-ray crystallography. The N₃S₂ ligand uses all donor atoms for complexation. The copper coordination is square pyramidal with one sulfur atom in the axial site. Ni(II) displays an octahedral coordination by an interaction with a water molecule. The Ag(I) coordination is best described as a distorted pentagonal bipyramid. In [CuL¹]²⁺ the 1, 4, 7-triazaheptane fragment of L¹ is meridionally coordinated, but facially in [NiL¹(H₂O)]²⁺ and intermediate in [AgL¹](ClO₄). Crystal data for [CuL¹](ClO₄)₂: monoclinic, space group P2₁/n, a = 13.153(8), b = 11.951(5), c = 17.880(8)Å, β = 110.29(4)°, Z = 4, R = 0.086 for 2732 independent reflections with I 2σ(I); [NiL¹(H₂O)](ClO₄)₂: monoclinic, P2₁/a, a = 10.771(2), b= 16.157(2), c = 15.286(2) Å, β =93.08(1)°, Z = 4, R = 0.085 for 1464 independent reflections with I 2σ(I); [AgL¹](ClO₄): monoclinic, P2₁/n, a = 12.708(9), b = 9.483(7), c = 19.569(13) Å, β= 103.95(6)°, Z = 4, R = 0.039 for 3600 independent reflections with I 2σ(I).     

Synthesis and characterization of new unsaturated macrobicyclic and bis(macrocyclic) copper(II) complexes containing N-CH2-N linkages

New copper(II) complexes [CuL²]²⁺ (L²=7,7,9-trimethyl-1,3,6,10,13-pentaazabicyclo[11,2,1^1.13]hexadec-9-ene) and [Cu₂(L³)(H₂O)₂]⁴⁺ have been prepared by the reaction of [CuL¹]²⁺ (L¹=5,5,7-trimethyl-1,4,8,11,14-pentaazatetradce-7-ene) and formaldehyde. The mononuclear complex [CuL²]²⁺ has a square-planar coordination geometry with a 5-6-5-6 chelate ring sequence and is relatively stable even in low pH at room temperature. The dinuclear complex [Cu₂(L³)(H₂O)₂]⁴⁺ consists of two unsaturated 15-membered pentaaza macrocyclic units (7,7,9-trimethyl-1,3,6,10,13-pentaazacyclopentadec-9-ene) that are linked together by a methylene group in a tilted face-to-face arrangement [Cu?Cu distance: 7.413(2) Å ]. Each macrocyclic unit of [Cu₂(L³)(H₂O)₂]⁴⁺ contains one four-membered chelate ring and has a severely distorted octahedral coordination polyhedron. The dinuclear complex is quite stable in aqueous solutions containing an excess of formaldehyde or in dry acetonitrile but is decomposed to [CuL¹]²⁺ and [CuL²]²⁺ in pure water.     

Copper(I)-organophosphine complexes of bis(3,5-dimethylpyrazol-1-yl)dithioacetate ligand

Copper(I) complexes have been synthesized from the reaction of CuCl, monodentate tertiary phosphines PR₃ (PR₃ = P(C₆H₅)₃; P(C₆H₅)₂(4-C₆H₄COOH); P(C₆H₅)₂(2-C₆H₄COOH); PTA, 1,3,5-triaza-7-phosphaadamantane; P(CH₂OH)₃, tris(hydroxymethyl)phosphine) and lithium bis(3,5-dimethylpyrazolyl)dithioacetate, Li[LCS₂]. Mono-nuclear complexes of the type [LCS₂]Cu[PR₃] have been obtained and characterized by elemental analyses, FT-IR, ESI-MS and multinuclear (¹H, ¹³C and ³¹P) NMR spectral data; in these complexes the ligand behaves as a κ³-N,N,S scorpionate system. One exception to this stoichiometry was observed in the complex [LCS₂]Cu[P(CH₂OH)₃]₂, where two phosphine co-ligands are coordinated to the copper(I) centre. The solid-state X-ray crystal structure of [LCS₂]Cu[P(C₆H₅)₃] has been determined. The [LCS₂]Cu[P(C₆H₅)₃] complex has a pseudo tetrahedral copper site where the bis(3,5-dimethylpyrazolyl)dithioacetate ligand acts as a κ³-N,N,S donor.     

A dithiocarbamate-stabilized copper(I) cube

The disproportionation reaction between the copper(II) complexes, Cu(ClO₄)₂ · 6H₂O and [Cu(S₂CNR₂)₂] is a well-established route to copper(III) complexes [Cu(S₂CNR₂)₂][ClO₄] but to date the nature of the copper(I) species generated has remained a mystery. We now show that with [Cu(S₂CNPr₂)₂] this is the copper(I) cluster, [Cu₈(μ²,μ²-S₂CNPr₂)₆][ClO₄]₂, which contains a cubic array of copper atoms, each face cube being capped by a dithiocarbamate ligand such that the sulfur atoms define an icosahedron and the backbone carbons an octahedron around the cube centroid. A crystal structure of [Cu₄(μ²,η¹-S₂CNBu₂)₄] is also presented for comparison.     

Copper-63 nuclear magnetic resonance studies of tris(triethyl phosphite)copper(I) chloride in nonaqueous solution

⁶³Cu and ³¹P NMR spectra of [CuL₃Cl] (L=triethylphosphite (1)in various nonaqueous solvents have been measured. It has been demonstrated that ligand-dissociation of 1 occurs to give [CuL₄]Cl (2) and low coordination copper(I) species. It has also been found that the formation of copper(I) species greatly depends on the solvent used. 1 and 2 give ⁶³Cu NMR signals while ⁶³Cu signals of other species are hardly observed due to significant line- broadening. By use of a dual NMR tube, 1 and 2 were determined quantitatively. It was found in a series of alcohols that 2 is preferred increasing solvent polarity. This is significantly associated with the cleavage of the CuCl bond.     

Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): Cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands

New copper(I) complexes containing the water soluble N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA) phosphine have been synthesized by ligand-exchange reactions starting from [Cu(CH₃CN)₄][BF₄] or [Cu(CH₃CN)₄][PF₆] precursors and (mPTA)X (X = CF₃SO₃, I). Depending on the ligand counter ion, the hydrophilic [Cu(mPTA)₄][(CF₃SO₃)₄(BF₄)] 3a and [Cu(mPTA)₄][(CF₃SO₃)₄(PF₆)] 3c complexes or the iodine-coordinated [Cu(mPTA)₃I]I₃4 species were obtained respectively and fully characterized by spectroscopic methods. Single crystal structural characterization was undertaken for [Cu(mPTA)₃I]I₃·H₂O, 4·H₂O, and [Cu(mPTA)₄][(CF₃SO₃)₂(BF₄)₃] ·0.25H₂O, 3b·0.25H₂O, the latter obtained by crystallization of [Cu(mPTA)₄][(CF₃SO₃)₄(BF₄)] 3a. The cytotoxicity of analogous tetrahedral homoleptic Cu(I) derivatives [Cu(PTA)₄](BF₄) 1, [Cu(PTAH)₄][Cl₄(BF₄)] 2, [Cu(mPTA)₄][(CF₃SO₃)₄(BF₄)] 3a and [Cu(mPTA)₄][(CF₃SO₃)₄(PF₆)] 3c was evaluated against a panel of several human tumor cell lines. All the complexes showed in vitro antitumor activity comparable to that of the reference metallodrug cisplatin. Tests performed on cisplatin sensitive and resistant cell lines showed that against human ovarian 2008/C13^* cell line pair, the resistance factor of copper derivatives was roughly 7-fold lower than that of cisplatin, whereas against human cervix cancer A431/A431-Pt cell line pair it was about 2.5-fold lower. These results, confirming the circumvention of cisplatin resistance, support the hypothesis that phosphine copper(I) complexes follow different cytotoxic mechanisms than do platinum drugs.     

Synthesis, structure and spectroscopic properties of 2,3-bis(diphenylphosphino)quinoxaline (dppQx) and its copper(I) complexes

Phosphinoquinoxalines were prepared by treatment of 2,3-dichloroquinoxaline (3) with phosphorus nucleophiles. The Arbuzov reaction of 3 with PPh(O-i-Pr)₂ gave a mixture of diastereomers of 2,3-(PPh(O)(O-i-Pr))₂quinoxaline (6); the crystal structure of rac-6 was determined, but attempts at reduction to yield bis(phenylphosphino)quinoxaline 7 resulted in P-C cleavage and formation of phenylphosphine. The bis(secondary phosphine) 7 could be generated from 3 and LiPHPh(BH₃), but was not isolated in pure form. Copper-catalyzed coupling of PHPh₂ with 3 gave 2,3-bis(diphenylphosphino)quinoxaline (4, dppQx), whose coordination chemistry was investigated, with comparison to data for the analogous 1,2-bis(diphenylphosphino)benzene (dppBz) complexes. Reaction of dppQx with [Cu(NCMe)₄][PF₆] gave [Cu(dppQx)₂][PF₆] (8); CuCl yielded [Cu(dppQx)Cl]₂ (9). Reaction of [Cu(NCMe)₄][PF₆] with one equiv of DPEphos, followed by one equiv of dppQx, gave [Cu(dppQx)(DPEphos)][PF₆] (10). Ligand 4 and copper complexes 8 and 9 were crystallographically characterized. The UV-Vis spectra of dppQx and its copper complexes were red-shifted from those of the dppBz analogs; in contrast to results for the dppBz complexes, those of dppQx were not luminescent in solution.     

Cationic copper(I) and silver(I) nitrile complexes with fluorinated weakly coordinating anions: Metal–nitrile bond strength and its influence on the catalytic performance

Copper(I) and silver(I) complexes of formulae [Cu(NCCH₃)₄]⁺[A]⁻ ([A]⁻ = [B(C₆F₅)₄]⁻ (1), {B[C₆H₃(CF₃)₂]₄}⁻ (2), [(C₆F₅)₃B–C₃H₃N₂–B(C₆F₅)₃]⁻ (3), and [Ag(NCCH₃)₄]⁺[B(C₆F₅)₄]⁻ (4) are examined with particular emphasis on the strength of their M–N bond and its influence on the catalytic performance of these complexes in cyclopropanation and aziridination. To examine the strength of the M–N interactions, vibrational spectra of the related hydrogenated and deuterated species [Cu(NCCH₃)₄]⁺, [Cu(NCCD₃)₄]⁺, [Ag(NCCH₃)₄]⁺, and [Ag(NCCD₃)₄]⁺ are also determined. It is found that the metal–nitrile bond strength is an important factor for the catalytic activity of the respective complexes.     

Synthesis and reactivity of binuclear halo-bridge palladium(II) isocyanide complexes

An equimolecular mixture of [Pd(RNC)₂Cl₂] (R = Ph, p-Me C₆H₄) and [Pd(MeCN)₂Cl₂] reacts in boiling, 1,2-dichloroethane to give the binuclear complexes [Pd(RNC)Cl₂]₂.These compounds undergo a variety of bridge-splitting reactions with neutral or anionic ligands yielding complexes of the type cis and trans [Pd(RNC)LX₂] or [Pd(RNC)X₃]⁻ (L = PPh₃, pyridine, C₆H₁₁NC; X = CL, Br).By reaction of [Pd(PhNC)Cl₃]⁻ with MeOH the anionic carbene complex [Pd{C(NHPh)OMe}Cl₃]⁻ is obtained.[Pd(PhNC)Cl₂]₂ reacts with p-toluidine (excess) or o-aminopyridine to give the corresponding mononuclear carbene derivatives.In the case of the mixed derivative [Pd(p-MeC₆H₄NC)(C₆H₁₁NC)Cl₂], only the more activated p-tolylisocyanide was found to react with p-toluidine.The complexes have been characterized by elemental analysis, conductivity measurements, i.r. and ¹H n.m.r. spectra where possible.     

Insertion reactions of 1,4-diisocyanobenzene in binuclear Pd(I) complexes

Reactions between XPd(μ-dmp)₂PdX′ (X = X′ = Cl, Br, I, NCO, SCN, N₃ or C₆F₅; X = C₆F₅, X′ = Cl, Br, I, NCO) with 1,4-diisocyanobenzene lead to the tetranuclear complexes [(μ,μ′-CNC₆H₄NC){XPd(μ-dpm)₂PdX′}₂], where both ends of the diisocyanide are inserted in a metalmetal bond. The cationic derivatives [(μ,μ′-CNC₆H₄NC){(RNC)Pd(μ-dpm)₂(CNR)}₂](BPh₄)₄ and [(μ,μ′-CNC₆H₄NC){(RNC)Pd(μ-dpm)₂Pd(C₆F₅)}₂] (BPh₄)₂ (R = p-Tol, Cy, or ^tBu) are obtained by reacting [(μ,μ′-CNC₆H₄NC){ClPd(μ-dpm)₂PdX}₂] (X= Cl or C₆F₅) with RNC in the presence of NaBPh₄. Treatment of [(μ,μ′-CNC₆H₄NC){ClPd(μ-dpm)₂Pd(C₆F₅)}]₂ with NaBPh₄ causes the di-insertion and subsequent coordination of the isocyanide, yielding [(C₆F₅)Pd(CN-C₆H₄NC) Pd(μ-dpm)₂Pd(C₆F₅)](BPh₄)₂.     

Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes

Gold(III) compounds have been recognized as anticancer agents due to their structural and electronic similarities with currently employed platinum(II) species. An added benefit to gold(III) agents is the ability to overcome cisplatin resistance. This work identified four gold(III) compounds, [Au(Phen)Cl₂]PF₆, [Au(DPQ)Cl₂]PF₆, [Au(DPPZ)Cl₂]PF₆, and [Au(DPQC)Cl₂]PF₆, (Phen = 1,10-phenanthroline, DPQ = dipyrido[3,2-d:2′,3′-f]quinoxaline, DPPZ = dipyrido[3,2-a:2′,3′-c] phenazine, DPQC = dipyrido[3,2-d:2′,3′-f] cyclohexyl quinoxaline) that exhibited anticancer activity in both cisplatin sensitive and cisplatin resistant ovarian cancer cells. Two of these compounds, [Au(DPQ)Cl₂]PF₆ (AQ) and [Au(DPPZ)Cl₂]PF₆ (AZ), displayed exceptional anticancer activity and were the focus of more intensive mechanistic study. At the molecular level, AQ and AZ formed DNA adducts, generated free radicals, and upregulated pro-apoptotic signaling molecules (p53, caspases, PARP, death effectors). Taken together, these two novel gold(III) polypyridyl complexes exhibit potent antitumor activity in cisplatin resistant cancer cells. These activities may be mediated, in part, by the activation of apoptotic signaling.     

Synthesis, structure, and catalytic activity of chiral silver(I) and copper(II) complexes with biaryl-based nitrogen-containing ligands

A series of chiral Ag(I) and Cu(II) complexes have been prepared from the reaction between AgX (X = NO₃, PF₆, OTf) or CuX₂ (X = Cl, ClO₄) and chiral biaryl-based N-ligands. The rigidity of the ligand plays an important role in the Ag(I) complex formation. For example, treatment of chiral N₃-ligands 1-3 with half equiv of AgX (X = NO₃, PF₆, OTf) gives the chiral bis-ligated four-coordinated Ag(I) complexes, while ligand 4 affords the two-coordinated Ag(I) complexes. Reaction of AgX with 1 equiv of chiral N₄-ligands 5, 7, 8 and 10 gives the chiral, binuclear double helicate Ag(I) complexes, while chiral mono-nuclear single helicate Ag(I) complexes are obtained with N₄-ligands 6 and 9. Treatment of either N₃-ligand 1 or N₄-ligand 9 or 10 with 1 equiv of CuX₂ (X = Cl, ClO₄) gives the mono-ligated Cu(II) complexes. All the complexes have been characterized by various spectroscopic techniques, and elemental analyses. Seventeen of them have further been confirmed by X-ray diffraction analyses. The Cu(II) complexes do not show catalytic activity for allylation reaction, in contrast to Ag(I) complexes, but they do exhibit catalytic activity for Henry reaction (nitroaldol reaction) that Ag(I) complexes do not.     

Cobalt(II) and nickel(II) complexes with nitrogen-sulfur tripod ligands. Crystal and molecular structure of the five-coordinate complex bromotris(2-tert-butylthioethyl)aminecobalt(II) hexafluorophosphate (NS3Br donor set)

The tripod ligands tris(2-alkylthioethyl)amine, with alkyl = ethyl, iso-propyl, and tert-butyl, give with cobalt(II) and nickel(II) halides high-spin complexes with formulae [MLX₂], [MLX]Y, and [MLX]₂[MX₄] (where X = Cl, Br, I; Y = BPh₄, PF₆). The nickel complexes are either six- or five-coordinate: the coordination number decreases as the bulkiness of the alkyl group bound to the sulfur is increased. All the cobalt complexes contain the five-coordinate cation [CoLX]⁺. The crystal and molecular structure of the [Co(NS₃-t-Bu)Br]PF₆ complex has been determined by standard X-ray methods, and refined to R = 0.061. The crystals are monoclinic, space group P2¹/n. The unit cell dimensions are: a = 27.420 (2), b = 11.923 (4), c = 17.082 (1) Å, β = 102.40 (1)°, Z = 8. The complex cation has a trigonal bipyramidal geometry with the nitrogen and bromine atoms at the apexes, and the three sulfur atoms in the equatorial plane. The tetrahedral distortion is relatively small (mean BrCoS angle = 98.5°), and similar to that found for the [Co (Me₆tren)Br]Br complex [Me₆tren = tris(2-dimethylaminoethyl)amine).     

Oxidation of copper(II)-coordinated diethylenetriamine by hexacyanoferrate(III) ion. A kinetic investigation

The stoichiometry and kinetics of the reaction between [Cu(dien)(OH)]⁺ and [Fe(CN)₆]³⁻ in aqueous alkaline medium are described. The rate equation − (d[Fe(III)]/dt = {k₁[OH⁻]²[[Cu(dien)(OH)]⁺] + k₂[OH⁻] × [[Cu(dien)(OH)]⁺]²}([Fe(III)]/[Fe(II)]) (Fe(III) = [Fe(CN)₆]³⁻; Fe(II) = [Fe(CN)₆]⁴⁻, the 4:4:1 OH⁻/Fe(III)/[Cu(dien)(OH)]⁺ stoichiometric ratio and the nature of the ultimate products identified in the reaction solution suggest the fast formation of a doubly deprotonated Cu(III)-diamido complex which slowly undergoes an internal redox process where the ligand is oxidised to the Schiff base H₂NCH₂CH₂NCHCHNH.The [[Cu(dien)(OH)]⁺]² term in the rate equation is explained with the formation of a transient μ-hydroxo mixed-valence Cu dimer. A two-electron internal reduction of the Cu(III) complex yielding a Cu(I) intermediate is suggested to account for the presence of monovalent copper in a precipitate which forms at relatively high reactant concentrations and in the absence of dioxygen.